Recent research by the National Cancer Institute says that more women are being diagnosed with the most dangerous form of skin cancer melanoma. Too much sun exposure and lack of safe sunscreens contribute extensively in the sharp increase of Melanoma. While everyone is recommended to have reasonable amount of sun exposure (here you need to consult your doctor because sun exposure is needed for Vitamin D as well) it's important that you share this news with family and friends about being cautious from the risk of melanoma.
Ads by Google
With a skin cancer rate among the 10 highest in the nation, Utah health officials are urging residents to take steps to keep their skin safe. Utah Department of Health (UDOH) data show that the rate of melanoma--the deadliest form of skin cancer--is increasing. In 2005, 554 Utahns were diagnosed with melanoma, up from 494 in 2004. Every year, melanoma kills an average of 63 Utah residents.
The good news is that skin cancer is preventable when sun protection measures are used consistently. UDOH and the Utah Cancer Action Network (UCAN) recommend:
Patient's own infection-fighting T cells put late-stage melanoma into long-term remission - without chemotherapy or radiation. Case is first to show safety and effectiveness of using cloned cells alone to kill tumors.
Disabling a protein frequently found in melanoma tumors may make the cancer more vulnerable to chemotherapy.
Results from an adjuvant trial in high-risk melanoma patients demonstrated that a majority of patients treated with Leukine (sargramostim) achieved disease-free and/or overall survival. These findings, which indicate Leukine's potential in this cancer setting, were released at the 44th annual meeting of the American Society of Clinical Oncology (ASCO).
Results from the Phase II study (ASCO abstract #20027) show that 60 percent of the 45 high-risk patients enrolled in the trial experienced disease-free survival and 64 percent of patients achieved overall survival at 21 months.
In this study, Genasense was used to potentially enhance the clinical activity of temozolomide, the most commonly used anticancer drug for melanoma, combined with Abraxane.
Scientists are urging everyone to take safety measures against sun rays during this summer and to protect themselves from skin cancer.
deCODE scientists and academic colleagues from Europe and US expand upon the company's recent findings in the genetics of pigmentation traits in people of European descent, and demonstrate that certain of these common variants also confer risk of two types of skin cancer.